Hyphens Pharma International Limited: Hyphens Pharma licenses Winlevi for all 10 ASEAN countries from Cosmo Pharmaceuticals
Winlevi is a first-in-class topical drug for the treatment of acne approved by U.S. FDA in August 2020.It will reinforce our Proprietary Brand segment's dermatological franchise. SINGAPORE,
Source: finanznachrichten.de
